These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7867991)

  • 21. Complications of multiple myeloma.
    Bladé J; Rosiñol L
    Hematol Oncol Clin North Am; 2007 Dec; 21(6):1231-46, xi. PubMed ID: 17996596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple myeloma.
    Oken MM
    Med Clin North Am; 1984 May; 68(3):757-87. PubMed ID: 6379340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The management of myelomatosis.
    Galton DA; Brito-Babapulle F
    Eur J Haematol; 1987 Nov; 39(5):385-98. PubMed ID: 2446915
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical characteristics and prognostic factors in multiple myeloma patients with light chain deposition disease.
    Mohan M; Buros A; Mathur P; Gokden N; Singh M; Susanibar S; Jo Kamimoto J; Hoque S; Radhakrishnan M; Matin A; Davis C; Grazziutti M; Thanendrarajan S; van Rhee F; Zangari M; Davies F; Morgan G; Epstein J; Barlogie B; Schinke C
    Am J Hematol; 2017 Aug; 92(8):739-745. PubMed ID: 28383130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and prognostic differences among patients with light chain deposition disease, myeloma cast nephropathy and both.
    Zand L; Nasr SH; Gertz MA; Dispenzieri A; Lacy MQ; Buadi FK; Kumar S; Kyle RA; Fervenza FC; Sethi S; Dingli D; Rajkumar SV; Kapoor P; McCurdy A; Leung N
    Leuk Lymphoma; 2015; 56(12):3357-64. PubMed ID: 25860232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemopoietic recovery and infectious complications in breast cancer and multiple myeloma after autologous CD34+ cell-selected peripheral blood progenitor cell transplantation.
    De Rosa L; Anghel G; Pandolfi A; Riccardi M; Amodeo R; Majolino I
    Int J Hematol; 2004 Jan; 79(1):85-91. PubMed ID: 14979484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Measures for infection in multiple myeloma].
    Horiuchi A; Azuma T
    Nihon Rinsho; 1995 Mar; 53(3):699-702. PubMed ID: 7699908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biphasic pattern of bacterial infection in multiple myeloma.
    Savage DG; Lindenbaum J; Garrett TJ
    Ann Intern Med; 1982 Jan; 96(1):47-50. PubMed ID: 6976144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term outcome according to renal histological lesions in 118 patients with monoclonal gammopathies.
    Montseny JJ; Kleinknecht D; Meyrier A; Vanhille P; Simon P; Pruna A; Eladari D
    Nephrol Dial Transplant; 1998 Jun; 13(6):1438-45. PubMed ID: 9641173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Renal impairment in patients with multiple myeloma.
    Chow CC; Mo KL; Chan CK; Lo HK; Wong KS; Chan JC
    Hong Kong Med J; 2003 Apr; 9(2):78-82. PubMed ID: 12668816
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Prognostic factors in light chain amyloidosis].
    Jávorniczky NR; Bodó I; Masszi T; Mikala G
    Orv Hetil; 2015 Sep; 156(39):1577-84. PubMed ID: 26550915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical and laboratory features and prognostic implications in myeloma with and without renal impairment].
    Griniūte R; Bumblyte IA
    Medicina (Kaunas); 2003; 39 Suppl 1():41-7. PubMed ID: 12761419
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of intact or fragmented immunoglobulin in urine of patients with multiple myeloma.
    Kraj M; Kruk B; Lech-Marańda E; Warzocha K; Prochorec-Sobieszek M
    Leuk Lymphoma; 2015; 56(12):3348-56. PubMed ID: 25860239
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of new patients with Bence-Jones, IgG and IgA myeloma receiving sequential therapy: the need to regard these immunologic subtypes as separate disease entities with specific prognostic criteria.
    Sirohi B; Powles R; Kulkarni S; Rudin C; Saso R; Lal R; Singhal S; Mehta J; Horton C; Treleaven J
    Bone Marrow Transplant; 2001 Jul; 28(1):29-37. PubMed ID: 11498741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Light chain myeloma: A brief report from India.
    Singh N; Agrawal N; Sekhri R; Mehta A; Kumar D; Vishwakarma G; Ahmed R; Bhurani D
    Indian J Pathol Microbiol; 2019; 62(3):441-444. PubMed ID: 31361235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
    Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
    Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal, hematologic and infectious complications in multiple myeloma.
    Bladé J; Rosiñol L
    Best Pract Res Clin Haematol; 2005; 18(4):635-52. PubMed ID: 16026742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Kappa and lambda light chain proteins--clinical and prognostic significance in patients with multiple myeloma.
    Goranov S
    Folia Med (Plovdiv); 1997; 39(2):52-7. PubMed ID: 9314667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Simplified response monitoring criteria for multiple myeloma in patients undergoing therapy with novel agents using computed tomography.
    Schabel C; Horger M; Kum S; Weisel K; Fritz J; Ioanoviciu SD; Bier G
    Eur J Radiol; 2016 Dec; 85(12):2195-2199. PubMed ID: 27842666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Infections complicating multiple myeloma and chronic lymphocytic leukemia.
    Twomey JJ
    Arch Intern Med; 1973 Oct; 132(4):562-5. PubMed ID: 4542660
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.